In re Actavis Holdco U.S., Inc. (In re Generic Pharmaceuticals Pricing Antitrust Litigation)

U.S. Court of Appeals for the Third Circuit

Tab Group

Petition Stage

Third Circuit denies en banc review

January 6, 2020

U.S. Chamber files amicus brief in support of petition for rehearing on discovery issue

December 23, 2019

Click here to view the U.S. Chamber’s brief. Bert W. Rein and Wesley E. Weeks of Wiley Rein LLP served as co-counse for the U.S. Chamber of Commerce on behalf of the U.S. Chamber Litigation Center.

Petition for writ of mandamus denied

December 6, 2019

A panel issued a divided opinion, rejecting a petition for writ of mandamus by a 2-1 order.

U.S. Chamber urges Third Circuit to grant petition for writ of mandamus & halt abusive discovery order requiring defendants to produce tens of millions of irrelevant, sensitive files matching broad search terms, without any opportunity for document review

November 8, 2019

The U.S. Chamber’s brief argued that the district court obviously erred in ordering the production of millions of documents without any relevance or privilege review, and that mandamus is warranted to correct this significant error.

Bert W. Rein and Wesley E. Weeks of Wiley Rein LLP served as co-counse for the U.S. Chamber of Commerce on behalf of the U.S. Chamber Litigation Center.

Case Documents

Petition for a Writ of Mandamus -- In re Generics Antitrust MDL (Third Circuit).pdf

U.S. Chamber Amicus Brief -- In re Generics Antitrust MDL (Third Circuit).pdf

Order -- In re Generics Antitrust MDL (Third Circuit).pdf

U.S. Chamber Amicus Brief iso Rehearing -- In re Generics Antitrust MDL (Third Circuit).pdf

Order Denying Rehearing -- In re Generics Antitrust MDL (Third Circuit).pdf